Results 141 to 150 of about 39,769 (244)

Investigating the role of EGFR signalling in muscle dystrophies: implications for Duchenne muscular dystrophy. [PDF]

Cell Death Dis
Fernández-Simón E, Tejedera-Villafranca A, Fernández-Garabay X, Clark J, Monceau A, Villalobos E, Cox D, Azcón JR, Fernández-Costa JM, Manera JD.   +9 more
europepmc   +1 more source

The clinical and molecular genetic approach to Duchenne and Becker muscular dystrophy: an updated protocol. [PDF]

, 1997
A. J. van Essen, Alexander L.J. Kneppers, Annemarie H. van der Hout, Hans Scheffer, Ieke B. Ginjaar, Leo P. ten Kate, G J van Ommen, Charles H.C.M. Buys, Egbert Bakker   +8 more
openalex   +1 more source

Serum protein biomarker signature of Duchenne muscular dystrophy

Paul Dowling, Elisa Négroni, Capucine Trollet, Margit Zweyer, Dieter Swandulla, Kay Ohlendieck   +5 more
openalex   +2 more sources

Pig models for translational Duchenne muscular dystrophy research [PDF]

Michael Stirm, Nikolai Klymiuk, Hiroshi Nagashima, Christian Kupatt, Eckhard Wolf   +4 more
openalex   +1 more source

Validation of DE50-MD dogs as a model for the brain phenotype of Duchenne muscular dystrophy

, 2022
Abbe Crawford, John Hildyard, Sophie A. M. Rushing, Dominic J. Wells, María Díez‐León, Richard J. Piercy   +5 more
openalex   +1 more source

Duchenne Muscular Dystrophy: Integrating Current Clinical Practice with Future Therapeutic and Diagnostic Horizons [PDF]

Costanza Montagna, Emiliano Maiani, Luisa Pieroni, Silvia Consalvi   +3 more
openalex   +1 more source

Magnetic resonance imaging in duchenne muscular dystrophy: Longitudinal assessment of natural history over 18 months [PDF]

, 2013
Kieren G. Hollingsworth, P. Garrood, Michelle Eagle, Kate Bushby, Volker Straub   +4 more
openalex   +1 more source

Advancing cardiac monitoring in adult Duchenne muscular dystrophy: longitudinal insights and real-world challenges. [PDF]

Int J Cardiol Heart Vasc
Tabary M, Wehrens XHT.
europepmc   +1 more source

Anti-inflammatory drugs for Duchenne muscular dystrophy: focus on skeletal muscle-releasing factors

, 2016
Yoshitsugu Aoki, Shouta Miyatake, Yuko Shimizu‐Motohashi, Shin’ichi Takeda   +3 more
openalex   +2 more sources

Lysosomal damage is a therapeutic target in Duchenne muscular dystrophy. [PDF]

Sci Adv
Jaber A, Palmieri L, Bakour R, Bourg N, Hong AV, Lachiver E, Roudaut C, Poupiot J, Albini S, Stockholm D, Van Wittenberghe L, Miranda A, Tanniou G, Danièle N, Barthélémy I, Blot S, Bui MT, Das B, Malfatti E, Evangelista T, Richard I, Israeli D.   +21 more
europepmc   +1 more source